Tazemetostat: First Approval.
- Published in:
- Drugs, 2020, v. 80, n. 5, p. 513, doi. 10.1007/s40265-020-01288-x
- By:
- Publication type:
- Article
Works matching IS 00126667 AND DT 2020 AND VI 80 AND IP 5
Results: 10
1
2
Teprotumumab: First Approval.
- Published in:
- Drugs, 2020, v. 80, n. 5, p. 509, doi. 10.1007/s40265-020-01287-y
- By:
- Publication type:
- Article
3
Cenegermin: A Review in Neurotrophic Keratitis.
- Published in:
- Drugs, 2020, v. 80, n. 5, p. 489, doi. 10.1007/s40265-020-01289-w
- By:
- Publication type:
- Article
4
Correction to: Ubrogepant: First Approval.
- Published in:
- Drugs, 2020, v. 80, n. 5, p. 523, doi. 10.1007/s40265-020-01292-1
- By:
- Publication type:
- Article
5
Trastuzumab Deruxtecan: First Approval.
- Published in:
- Drugs, 2020, v. 80, n. 5, p. 501, doi. 10.1007/s40265-020-01281-4
- By:
- Publication type:
- Article
6
Third-Line Antidiabetic Therapy Intensification Patterns and Glycaemic Control in Patients with Type 2 Diabetes in the USA: A Real-World Study.
- Published in:
- Drugs, 2020, v. 80, n. 5, p. 477, doi. 10.1007/s40265-020-01279-y
- By:
- Publication type:
- Article
7
Glucokinase Activators for Type 2 Diabetes: Challenges and Future Developments.
- Published in:
- Drugs, 2020, v. 80, n. 5, p. 467, doi. 10.1007/s40265-020-01278-z
- By:
- Publication type:
- Article
8
Osilodrostat: First Approval.
- Published in:
- Drugs, 2020, v. 80, n. 5, p. 495, doi. 10.1007/s40265-020-01277-0
- By:
- Publication type:
- Article
9
TSLP Inhibitors for Asthma: Current Status and Future Prospects.
- Published in:
- Drugs, 2020, v. 80, n. 5, p. 449, doi. 10.1007/s40265-020-01273-4
- By:
- Publication type:
- Article
10
Mechanisms of Resistance to PD-1 Checkpoint Blockade.
- Published in:
- Drugs, 2020, v. 80, n. 5, p. 459, doi. 10.1007/s40265-020-01270-7
- By:
- Publication type:
- Article